AIM: To investigate the inhibitive effects of triptolide (TPL) combined with 5-fluorouracil (5-FU) on colon carcinoma HT-29 cells in vitro and in vivo and their side effects. METHODS: HT-29 cells were cultured with RPMI 1640 medium. The single or combined effects of TPL and 5-FU on HT-29 cells were examined by MTT assay, flow cytometry. The combined effects were evaluated by the median-effect principle. The model of tumour xenografts was established in nude mice. TPL 0.25 mg/kg/day and 5-FU 12 mg/kg/day, either in combination or on their own, were injected into mice and the inhibitive effects and side effects were observed. RESULTS: TPL and 5-FU either combined or alone inhibited significantly the proliferation of HT-29 cells and induced obvious apoptosis. Mean (SD) growth inhibition rate reached 94.92 (2.76)% and the apoptic rate at 48 h reached 41.71 (1.38)%. The combined effects were synergistic (CI<1) at lower concentrations. TPL or 5-FU alone inhibited significantly the growth of tumour xenografts and the inhibition rates were 78.53% and 84.16%; the drugs combined had more significant effect, the tumour inhibition rate reaching 96.78%. During the course of chemotherapy, no obvious side effect was observed. CONCLUSION: The combined effects of TPL and 5-FU on the growth of colon carcinoma in vitro and in vivo were superior to the effects when the agents were used individually. TPL combined with 5-FU had synergistic effects at lower concentrations and promoted apoptosis, but did not increase the side effects of chemotherapy.
AIM: To investigate the inhibitive effects of triptolide (TPL) combined with 5-fluorouracil (5-FU) on colon carcinoma HT-29 cells in vitro and in vivo and their side effects. METHODS: HT-29 cells were cultured with RPMI 1640 medium. The single or combined effects of TPL and 5-FU on HT-29 cells were examined by MTT assay, flow cytometry. The combined effects were evaluated by the median-effect principle. The model of tumour xenografts was established in nude mice. TPL 0.25 mg/kg/day and 5-FU 12 mg/kg/day, either in combination or on their own, were injected into mice and the inhibitive effects and side effects were observed. RESULTS:TPL and 5-FU either combined or alone inhibited significantly the proliferation of HT-29 cells and induced obvious apoptosis. Mean (SD) growth inhibition rate reached 94.92 (2.76)% and the apoptic rate at 48 h reached 41.71 (1.38)%. The combined effects were synergistic (CI<1) at lower concentrations. TPL or 5-FU alone inhibited significantly the growth of tumour xenografts and the inhibition rates were 78.53% and 84.16%; the drugs combined had more significant effect, the tumour inhibition rate reaching 96.78%. During the course of chemotherapy, no obvious side effect was observed. CONCLUSION: The combined effects of TPL and 5-FU on the growth of colon carcinoma in vitro and in vivo were superior to the effects when the agents were used individually. TPL combined with 5-FU had synergistic effects at lower concentrations and promoted apoptosis, but did not increase the side effects of chemotherapy.
Authors: P N Huynh; A P Hikim; C Wang; K Stefonovic; Y H Lue; A Leung; V Atienza; S Baravarian; V Reutrakul; R S Swerdloff Journal: J Androl Date: 2000 Sep-Oct
Authors: John M Fidler; Ke Li; Cathie Chung; Ke Wei; Jessica A Ross; Mingxing Gao; Glenn D Rosen Journal: Mol Cancer Ther Date: 2003-09 Impact factor: 6.261
Authors: Pek Leng Ng; Nor Fadilah Rajab; Sue Mian Then; Yasmin Anum Mohd Yusof; Wan Zurinah Wan Ngah; Kar Yong Pin; Mee Lee Looi Journal: J Zhejiang Univ Sci B Date: 2014-08 Impact factor: 3.066
Authors: Michael McCulloch; Helen Ly; Michael Broffman; Caylie See; Jen Clemons; Raymond Chang Journal: Integr Cancer Ther Date: 2016-05-04 Impact factor: 3.279
Authors: Ilona Rousalova; Sulagna Banerjee; Veena Sangwan; Kristen Evenson; Joel A McCauley; Robert Kratzke; Selwyn M Vickers; Ashok Saluja; Jonathan D'Cunha Journal: PLoS One Date: 2013-10-15 Impact factor: 3.240